Business Description
Concord Medical Co Ltd
ISIN : TW0006518004
Total Employee Number:
26Description
Concord Medical Co Ltd is a Taiwan based company involved in providing hospital management support services including medical equipment leasing, pharmaceuticals, and medical consumables integrated supply. . The company's main business items are medical equipment, pharmaceuticals Product trading business, leasing business and management consulting services.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.51 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.26 | |||||
Debt-to-EBITDA | 1.09 | |||||
Interest Coverage | 18.7 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.88 | |||||
Beneish M-Score | -2.81 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.5 | |||||
3-Year EBITDA Growth Rate | 5.8 | |||||
3-Year EPS without NRI Growth Rate | 10.2 | |||||
3-Year FCF Growth Rate | 1.3 | |||||
3-Year Book Growth Rate | 2.7 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 11.9 | |||||
9-Day RSI | 29.52 | |||||
14-Day RSI | 39.76 | |||||
6-1 Month Momentum % | 20.27 | |||||
12-1 Month Momentum % | 21.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.78 | |||||
Quick Ratio | 1.76 | |||||
Cash Ratio | 0.84 | |||||
Days Inventory | 2.62 | |||||
Days Sales Outstanding | 94.54 | |||||
Days Payable | 99.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 4.9 | |||||
Dividend Payout Ratio | 0.55 | |||||
3-Year Dividend Growth Rate | 30.1 | |||||
Forward Dividend Yield % | 4.9 | |||||
5-Year Yield-on-Cost % | 16 | |||||
Shareholder Yield % | 4.94 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 13.89 | |||||
Operating Margin % | 7.55 | |||||
Net Margin % | 6.99 | |||||
EBITDA Margin % | 17.8 | |||||
FCF Margin % | 12.65 | |||||
OCF Margin % | 16.31 | |||||
ROE % | 9.56 | |||||
ROA % | 5.65 | |||||
ROIC % | 9.23 | |||||
3-Year ROIIC % | 8.12 | |||||
ROC (Joel Greenblatt) % | 57.81 | |||||
ROCE % | 9.92 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 15.13 | |||||
PE Ratio without NRI | 15.12 | |||||
Shiller PE Ratio | 26.02 | |||||
Price-to-Owner-Earnings | 8.74 | |||||
PS Ratio | 1.06 | |||||
PB Ratio | 1.39 | |||||
Price-to-Tangible-Book | 1.43 | |||||
Price-to-Free-Cash-Flow | 8.36 | |||||
Price-to-Operating-Cash-Flow | 6.48 | |||||
EV-to-EBIT | 10.87 | |||||
EV-to-EBITDA | 5.5 | |||||
EV-to-Revenue | 0.98 | |||||
EV-to-FCF | 8.05 | |||||
Price-to-GF-Value | 1.04 | |||||
Price-to-Projected-FCF | 0.81 | |||||
Price-to-Median-PS-Value | 1.36 | |||||
Price-to-Graham-Number | 0.98 | |||||
| Price-to-Net-Current-Asset-Value | 9.27 | |||||
Earnings Yield (Greenblatt) % | 9.18 | |||||
FCF Yield % | 12.04 | |||||
Forward Rate of Return (Yacktman) % | 4.66 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Concord Medical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 964.351 | ||
| EPS (TTM) (NT$) | 2.01 | ||
| Beta | -0.219 | ||
| 3-Year Sharpe Ratio | 0.21 | ||
| 3-Year Sortino Ratio | 0.35 | ||
| Volatility % | 18.22 | ||
| 14-Day RSI | 39.76 | ||
| 14-Day ATR (NT$) | 0.713785 | ||
| 20-Day SMA (NT$) | 31.9875 | ||
| 12-1 Month Momentum % | 21.92 | ||
| 52-Week Range (NT$) | 25.5 - 53.6 | ||
| Shares Outstanding (Mil) | 33.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Concord Medical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Concord Medical Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 1.500000 Cash Dividend | 2026-04-10 | 27.70 (+0.73%) | ||
| TWD 1.100000 Cash Dividend | 2025-04-10 | 24.00 (-1.03%) |
Show
Entries
Concord Medical Co Ltd Frequently Asked Questions
What is Concord Medical Co Ltd(ROCO:6518)'s stock price today?
The current price of ROCO:6518 is NT$30.40. The 52 week high of ROCO:6518 is NT$53.60 and 52 week low is NT$25.50.
When is next earnings date of Concord Medical Co Ltd(ROCO:6518)?
The next earnings date of Concord Medical Co Ltd(ROCO:6518) is .
Does Concord Medical Co Ltd(ROCO:6518) pay dividends? If so, how much?
The Dividend Yield %  of Concord Medical Co Ltd(ROCO:6518) is 4.9% (As of Today), Highest Dividend Payout Ratio of Concord Medical Co Ltd(ROCO:6518) was 13.33. The lowest was 0.31. And the median was 0.55. The  Forward Dividend Yield % of Concord Medical Co Ltd(ROCO:6518) is 4.9%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Concord Medical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers